Join
Live feed
·
PRReleasevia Quantisnow
Corvus Pharmaceuticals Inc. logo

Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M

ByQuantisnow·Wall Street's wire, on your screen.
CRVS· Corvus Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRVS (Corvus Pharmaceuticals Inc.) and more on Quantisnow.